logo
logo
search
Invest in China > Hainan > Newsroom > Success Stories
Facebook Twitter

Sanofi signed strategic cooperation agreement with Boao medical tourism pilot zone

Updated: govt.chinadaily.com.cn

Location: Boao Lecheng International Medical Tourism Pilot Zone

Sector: Medicine and Medical Technology

Investment Model: Researching drugs and vaccines and establishing Sanofi Real-World Study Center

On November 9, 2020, French pharmaceutical company Sanofi Group signed a strategic cooperation agreement with Boao Lecheng International Medical Tourism Pilot Zone Administration at the third China International Import Expo.

The cooperation covers an 'everlasting' medical instrument exhibition, drug and vaccines research, real-world statistics studies, Lecheng's global special drug insurance, and more. Both sides will use their advantages to bring more globally innovative and clinically urgent medicines to China, in order to improve the quality of diagnosis and treatment and the affordability of care, while also improving the accessibility of high-quality and innovative medical products and services.

Zhu Hailuan, the vice-president of Sanofi China Public Affairs and Market Access, noted that the strategic cooperation agreement marks a new stage in cooperation. In the future, with the unique and groundbreaking policies of the Lecheng Pilot Zone, Sanofi will actively promote the use of the world’s leading innovative drugs and vaccines in Lecheng so as to benefit more Chinese patients and contribute to the Healthy China 2030 campaign.

On December 20, Boao Lecheng International Medical Tourism Pilot Zone signed a strategic cooperation agreement with Sanofi, establishing the Sanofi Real-World Study Center in Pilot Zone.

Sanofi, a French world-renowned international healthcare group, has been in business for over 100 years and ranks among the top 100 pharmaceutical companies in the world. Sanofi Real-World Study Center, the first real-world study center to be built in the Pilot Zone by multinational companies, aims to take advantage of the unique policies of the Pilot Zone and utilize real-world clinical data to conduct research into the evaluation of new drugs. Over the next five years, Sanofi plans to introduce more than 20 new drugs into the Pilot Zone.

HOW WE HELP

CONTACT US
Tell us your special needs and let us facilitate your investment in Hainan
Top
© 2021 China Daily. All Rights Reserved.